NCT06423625

Brief Summary

Developing a prediction score model for predicting the likelihood of Hemorrhagic MI

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
252

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 21, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2025

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2025

Completed
Last Updated

January 6, 2026

Status Verified

January 1, 2026

Enrollment Period

2.5 years

First QC Date

May 16, 2024

Last Update Submit

January 3, 2026

Conditions

Acute Myocardial Infarction

Keywords

Acute Myocardial InfarctionPrediction ScoreMachine LearningHemorrhagic MI

Outcome Measures

Primary Outcomes (1)

  • Hemorrhagic MI

    Percentage of MI patients confirmed as Hemorrhagic MI

    Emergency admission to Percutaneous Intervention

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of individuals aged 18 - 80 yrs who have been diagnosed with acute ST-elevation myocardial infarction (STEMI) and are scheduled for emergency percutaneous coronary intervention (PCI).

You may qualify if:

  • Age \> 18 yrs
  • Index MI
  • Primary PCI

You may not qualify if:

  • History of prior myocardial infarction,
  • Thrombolysis before PCI
  • Contraindication to Cardiac MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Krannert Cardiovascular Research Center, Indiana University School of Medicine

Indianapolis, Indiana, 46202, United States

Location

Study Officials

  • Keyur P Vora, MD FACC

    Indiana University School of Medicine, Krannert Cardiovascular Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Executive Director, Krannert Cardiovascular Research Center

Study Record Dates

First Submitted

May 16, 2024

First Posted

May 21, 2024

Study Start

June 1, 2023

Primary Completion

December 15, 2025

Study Completion

December 20, 2025

Last Updated

January 6, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations

US(1)